| Literature DB >> 22701793 |
Dominik Ketelsen1, Markus Buchgeister, Andreas Korn, Michael Fenchel, Bernhard Schmidt, Thomas G Flohr, Christoph Thomas, Christoph Schabel, Ilias Tsiflikas, Roland Syha, Claus D Claussen, Martin Heuschmid.
Abstract
Purpose. To estimate effective dose and organ equivalent doses of prospective ECG-triggered high-pitch CTCA. Materials and Methods. For dose measurements, an Alderson-Rando phantom equipped with thermoluminescent dosimeters was used. The effective dose was calculated according to ICRP 103. Exposure was performed on a second-generation dual-source scanner (SOMATOM Definition Flash, Siemens Medical Solutions, Germany). The following scan parameters were used: 320 mAs per rotation, 100 and 120 kV, pitch 3.4 for prospectively ECG-triggered high-pitch CTCA, scan range of 13.5 cm, collimation 64 × 2 × 0.6 mm with z-flying focal spot, gantry rotation time 280 ms, and simulated heart rate of 60 beats per minute. Results. Depending on the applied tube potential, the effective whole-body dose of the cardiac scan ranged from 1.1 mSv to 1.6 mSv and from 1.2 to 1.8 mSv for males and females, respectively. The radiosensitive breast tissue in the range of the primary beam caused an increased female-specific effective dose of 8.6%±0.3% compared to males. Decreasing the tube potential, a significant reduction of the effective dose of 35.8% and 36.0% can be achieved for males and females, respectively (P < 0.001). Conclusion. The radiologist and the CT technician should be aware of this new dose-saving strategy to keep the radiation exposure as low as reasonablly achievable.Entities:
Year: 2012 PMID: 22701793 PMCID: PMC3371345 DOI: 10.1155/2012/724129
Source DB: PubMed Journal: Radiol Res Pract ISSN: 2090-195X
Effective radiation exposure of high-pitch CTCA using 100 kV and 120 kV.
| Protocol | Effective dose male [mSv] | Effective dose female [mSv] | Total mAs | CTDIVol (mGy) | DLP (mGy cm) |
|---|---|---|---|---|---|
| 1 (100 kV) | 1.1 | 1.2 | 688 | 3.1 | 56 |
| 2 (120 kV) | 1.6 | 1.8 | 689 | 5.2 | 95 |
CTDIVol: volume CT dose index; DLP: dose-length product.
Measured organ equivalent doses of high-pitch CTCA using different tube voltages (mSv).
| Organ/tissue | 100 kV | 120 kV |
|---|---|---|
| Thyroid gland | 0.03 | 0.04 |
| Esophagus | 0.05 | 0.05 |
| Lung | 0.20 | 0.33 |
| Breast | 0.07 | 0.13 |
| Stomach | 0.45 | 0.67 |
| Liver | 0.06 | 0.12 |
| Colon | 0.03 | 0.03 |
| Urinary bladder | 0.00 | 0.00 |
| Red bone marrow | 0.01 | 0.02 |
| Skeleton | 0.00 | 0.00 |
| Skin | 0.00 | 0.01 |
| Male gonads | 0.00 | 0.00 |
| Female gonads | 0.01 | 0.01 |
| Remaining organs | 0.22 | 0.37 |